Intuitive Machines Has 7 NASA Missions on the Manifest. Is the Stock Finally Worth Owning?

Intuitive Machines’ NASA backlog is cited at $1.8B as of Q2 2026—nearly double its projected 2026 revenue of $918M—after adding multiple lunar surface missions (IM-1 to IM-5) and orbital satellite buses (IM 300/IM 500). The company is expected to grow revenue from 2026 to 2028 at a 16% CAGR to $1.23B, with adjusted EBITDA rising from under $3M to $79M. Despite two lunar landers (IM-1 and IM-2) tipping over, both transmitted data, and the stock is described as “reasonably valued” at ~2x next year’s sales and ~47x adjusted EBITDA, with upside contingent on hitting scheduled launches and winning further NASA/DoD/commercial contracts.

Analysis

The market is starting to price LUNR like a programmatic defense prime, but the business still behaves more like a binary execution story than a stable compounder. The real asset is not backlog per se; it is customer trust that can survive a few mission mishaps long enough for revenue to convert into cash flow. That makes the stock highly sensitive to any slip in launch cadence, integration risk from acquisitions, or signs that working capital needs are rising faster than contract wins.

Second-order, the biggest competitive threat is not another pure-play moonshot company so much as larger incumbents and adjacent space systems vendors with better balance sheets and lower execution volatility. If NASA and DoD keep rewarding LUNR after visible failures, that lowers the barrier for other specialist contractors to bid aggressively; if they do not, awards can migrate to names with broader platform breadth like RKLB or defense primes with space exposure. In either case, the valuation multiple only works if management proves it can turn mission visibility into margin expansion over the next 6-18 months.

Contrarian view: the consensus may be overconfident in the backlog as a moat. Backlog at this stage is a scheduling claim, not a guarantee of profitability, and the market is implicitly assuming the EBITDA inflection arrives on time; one or two delayed programs would push that out materially and likely compress the multiple before estimates move. The stock has already rerated significantly, so upside from here is more dependent on clean execution than on incremental headline wins.

Key Decisions for Investors

• Do not chase LUNR after the rerating; treat it as a hold/trim unless the stock pulls back 10-15% on no change in contract cadence. Time horizon: 6-18 months, with the thesis invalidated by launch slippage or a 2027 guide that fails to show margin inflection.
• If you want exposure, use a small starter long in LUNR only after a successful operational milestone or a clean quarterly report that shows backlog conversion, not just backlog growth. Risk/reward is acceptable only if the market begins capitalizing 2028 EBITDA; otherwise downside from multiple compression outweighs near-term upside.
• Relative-value expression: long LUNR / short RKLB for 1-3 months if you expect NASA/DoD awards to continue favoring lunar mission specialization over broader space beta. This works only if LUNR keeps executing; cover if RKLB wins a comparable mission or if LUNR misses a launch window.
• Set a hard alert for the next earnings release: if adjusted EBITDA guidance does not step up meaningfully or cash burn rises faster than revenue, fade the rally. That would falsify the 'backlog-to-profitability' thesis and likely reset the stock lower.